Literature DB >> 21177058

2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

L Samuel Wann, Anne B Curtis, Craig T January, Kenneth A Ellenbogen, James E Lowe, N A Mark Estes, Richard L Page, Michael D Ezekowitz, David J Slotwiner, Warren M Jackman, William G Stevenson, Cynthia M Tracy, Valentin Fuster, Lars E Rydén, David S Cannom, Jean-Yves Le Heuzey, Harry J Crijns, James E Lowe, Anne B Curtis, S Bertil Olsson, Kenneth A Ellenbogen, Eric N Prystowsky, Jonathan L Halperin, Juan Luis Tamargo, G Neal Kay, L Samuel Wann, Alice K Jacobs, Jeffrey L Anderson, Nancy Albert, Judith S Hochman, Christopher E Buller, Frederick G Kushner, Mark A Creager, Erik Magnus Ohman, Steven M Ettinger, William G Stevenson, Robert A Guyton, Lynn G Tarkington, Jonathan L Halperin, Clyde W Yancy.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 21177058     DOI: 10.1016/j.jacc.2010.10.001

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  76 in total

1.  Identifying a high stroke risk subgroup in individuals with heart failure.

Authors:  Patrick M Pullicino; Leslie A McClure; Virginia J Howard; Virginia G Wadley; Monika M Safford; James F Meschia; Aaron Anderson; George Howard; Elsayed Z Soliman
Journal:  J Stroke Cerebrovasc Dis       Date:  2011-12-03       Impact factor: 2.136

Review 2.  Barriers to translating EU and US CVD guidelines into practice in China.

Authors:  Dong Zhao; Dayi Hu
Journal:  Nat Rev Cardiol       Date:  2012-05-01       Impact factor: 32.419

Review 3.  Atrial fibrillation ablation in octogenarians: where do we stand?

Authors:  Gevorg Stepanyan; Edward P Gerstenfeld
Journal:  Curr Cardiol Rep       Date:  2013-10       Impact factor: 2.931

4.  Weighted gene coexpression network analysis of human left atrial tissue identifies gene modules associated with atrial fibrillation.

Authors:  Nicholas Tan; Mina K Chung; Jonathan D Smith; Jeffrey Hsu; David Serre; David W Newton; Laurie Castel; Edward Soltesz; Gosta Pettersson; A Marc Gillinov; David R Van Wagoner; John Barnard
Journal:  Circ Cardiovasc Genet       Date:  2013-07-17

5.  Adherence to guideline recommendations for antiarrhythmic drugs in atrial fibrillation.

Authors:  Nancy M Allen LaPointe; Yuliya Lokhnygina; Gillian D Sanders; Eric D Peterson; Sana M Al-Khatib
Journal:  Am Heart J       Date:  2013-09-24       Impact factor: 4.749

6.  Personalized, assessment-based, and tiered medical education curriculum integrating treatment guidelines for atrial fibrillation.

Authors:  Brian C Lee; Karyn D Ruiz-Cordell; Steven M Haimowitz; Cara Williams; Bruce S Stambler; Anthia Mandarakas
Journal:  Clin Cardiol       Date:  2017-01-31       Impact factor: 2.882

7.  Highlights from the IV International Symposium of Thrombosis and Anticoagulation (ISTA), October 20-21, 2011, Salvador, Bahia, Brazil.

Authors:  Renato D Lopes; Richard C Becker; L Kristin Newby; Eric D Peterson; Elaine M Hylek; Christopher B Granger; Mark Crowther; Tracy Wang; Antonio C Carvalho; Otavio Berwanger; Roberto R Giraldez; Gilson Soares Feitosa; Jorge Pinto Ribeiro; Eduardo Darze; Renato A K Kalil; Marianna Andrande; Fabio Villas Boas; Jadelson Andrade; Ana Thereza Rocha; Robert A Harrington; Antonio C Lopes; David A Garcia
Journal:  J Thromb Thrombolysis       Date:  2012-07       Impact factor: 2.300

8.  Pharmacologic strategies for the prevention of stroke in patients with atrial fibrillation.

Authors:  Greg Flaker; Richard Weachter
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-10

Review 9.  Benefit-risk assessment of dronedarone in the treatment of atrial fibrillation.

Authors:  Ahmed M A Adlan; Gregory Y H Lip
Journal:  Drug Saf       Date:  2013-02       Impact factor: 5.606

Review 10.  [Anticoagulation in geriatric patients with atrial fibrillation : With what and for whom no more?]

Authors:  P Bahrmann; M Christ
Journal:  Herz       Date:  2018-05       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.